metastatic directed therapy (esp with... - Fight Prostate Ca...

Fight Prostate Cancer

3,030 members1,511 posts

metastatic directed therapy (esp with SRBT), the approach is shifting

Maxone73 profile image
6 Replies

I am a bit disappointed, most of the doctors interviewed for the original article are Italian, yet in Italy this approach is not widespread….bah

Metastasis-directed therapy (MDT), particularly stereotactic body radiotherapy (SBRT), is transforming metastatic prostate cancer treatment by offering tailored strategies that move beyond traditional lifelong androgen deprivation therapy (ADT). Studies like STOMP and ORIOLE have shown that MDT can significantly delay the initiation of ADT and improve progression-free survival. Combining MDT with short-term ADT, as explored in the EXTEND trial, has further enhanced outcomes, allowing patients to maintain normal testosterone levels longer. In cases of oligoprogressive castration-resistant prostate cancer, the ARTO trial demonstrated that MDT could delay the need for additional systemic therapies. Additionally, the PROLONG study found that MDT, when used alongside systemic therapies for de novo low-volume hormone-sensitive prostate cancer, improved survival. Even in polymetastatic disease, MDT has proven to be a safe and feasible option. These findings indicate that MDT is not only effective but also adaptable, offering patients more personalized treatment approaches while improving their quality of life.

prostatewarriors.com/2025/0...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
6 Replies
dhccpa profile image
dhccpa

Wouldn't it hurt the drug makers? I mean, is that possible?

Maxone73 profile image
Maxone73 in reply todhccpa

Competition is always good, plus there are sbrt machines makers as well 😀

dhccpa profile image
dhccpa in reply toMaxone73

I wonder if the two groups ever have a real shootout.

Seriously, I like the idea of spot radiation. I think others Pooh Pooh it.

Maxone73 profile image
Maxone73 in reply todhccpa

I like the idea too, I should contact one of the Dr that wrote the original report in Milan. Where I go, even if a center of excellence they would consider srbt only palliative if I had symptoms. But now my pet scan says that even if still active, my mets are not as many as before. I would give it a try to enhance triplet therapy

GreenStreet profile image
GreenStreet

Its pretty much what I have been doing. I am oligometastic and had Cyberknife treatement to a lymph node plus 6 months bicalutamide to knock it back. That was over 3 years ago. £ monthly PSA monitoring. Expect further treatment soon based on PSA progression but most recent Pet Scan has not located anything

cigafred profile image
cigafred

I had it based on the attached MRI summary. N=1, but seems to have been good for me.

MRI

Not what you're looking for?

You may also like...

Phase 2 trial: adaptive ADT for metastatic castration sensitive prostate cancer

The H. Lee Moffitt Cancer Center is advancing prostate cancer treatment with a Phase 2 trial...
Maxone73 profile image

Phase 2 BAT trial recruiting soon: BAT + ZEN-3694, Denmeade strikes again!

The COSMYC Trial is a Phase 2 clinical trial investigating a novel sequential treatment strategy...
Maxone73 profile image

Phase 3 ended: ECLIPSE trial of 177Lu-PSMA-I&T

A phase 3 clinical trial called ECLIPSE has shown that 177Lu-PSMA-I&T significantly extends the...
Maxone73 profile image

Phase 2 BAT trial from downunder: WOMBAT trial

The WOMBAT Trial (Working Out M0 Bipolar Androgen Therapy) investigates the efficacy of bipolar...
Maxone73 profile image

Welcoming New Era of Expanded Use of Radiotherapies

Duplicating this for my friends at FPC. This is the short take from Practice Update this morning....
MateoBeach profile image